Markets Insider: Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting Healio: Most patients with focal epilepsy still have seizures during first year of treatment Most patients with focal epilepsy still have seizures during first year of treatment The Globe and Mail: Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting Please provide your email address to receive an email when new articles are posted on . Patients with focal nonmotor seizures experienced a delay from first seizure to diagnosis that was 10 times ... The American Journal of Managed Care: Seizures While Driving Highlight Importance of Early Focal Epilepsy Awareness, Diagnosis Early detection of focal epilepsy may reduce the amount of motor vehicle accidents caused by seizures while driving.
The prevalence of seizures while driving (SzWD) prior to diagnosis in people with ... News Medical: People with focal epilepsy often have seizures while driving before a diagnosis People with focal epilepsy often have seizures while driving before a diagnosis
